about
Magnitude of the disease burden from neurocysticercosis in a developing countryEvaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheepCharacterization of a novel Taenia solium oncosphere antigen.Chagas cardiomyopathy in the context of the chronic disease transition.Regional variation in the correlation of antibody and T-cell responses to Trypanosoma cruzi.Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia.A history of chagas disease transmission, control, and re-emergence in peri-rural La Joya, PeruA field trial of alternative targeted screening strategies for Chagas disease in Arequipa, Peru.Field evaluation of the InBios Chagas detect plus rapid test in serum and whole-blood specimens in BoliviaTaenia solium infection in Peru: a collaboration between Peace Corps Volunteers and researchers in a community based study.Anti-triatomine saliva immunoassays for the evaluation of impregnated netting trials against Chagas disease transmission.Cavia porcellus as a model for experimental infection by Trypanosoma cruziNeurocysticercosis: A natural human model of epileptogenesis.Trypanosoma cruzi-infected pregnant women without vector exposure have higher parasitemia levels: implications for congenital transmission risk.Prevalence and Transmission of Trypanosoma cruzi in People of Rural Communities of the High Jungle of Northern Peru.In response: Multifactorial basis of epilepsy in patients with neurocysticercosisThe highly antigenic 53/25 kDa Taenia solium protein fraction with cathepsin-L like activity is present in the oncosphere/cysticercus and induces non-protective IgG antibodies in pigsSustained Domestic Vector Exposure Is Associated With Increased Chagas Cardiomyopathy Risk but Decreased Parasitemia and Congenital Transmission Risk Among Young Women in BoliviaIn Vitro Study of Taenia solium Postoncospheral Form.Domestic Pig (Sus scrofa) as an Animal Model for Experimental Trypanosoma cruzi Infection.Etiological Role and Repeated Infections of Sapovirus among Children Aged Less than 2 Years in a Cohort Study in a Peri-urban Community of Peru.Neurocysticercal antigens stimulate chemokine secretion from human monocytes via an NF-kappaB-dependent pathway.Synthesis, cytotoxicity, and anti-Trypanosoma cruzi activity of new chalcones.Novel rat model for neurocysticercosis using Taenia solium.Taenia solium oncosphere adhesion to intestinal epithelial and Chinese hamster ovary cells in vitro.Correction: Prevalence and Transmission of Trypanosoma cruzi in People of Rural Communities of the High Jungle of Northern Peru.Human and porcine Taenia solium infection in a village in the highlands of Cusco, Peru. The Cysticercosis Working Group in Peru.Cytotoxic and anti-infective sesquiterpenes present in Plagiochila disticha (Plagiochilaceae) and Ambrosia peruviana (Asteraceae).Seroincidence of porcine T. solium infection in the Peruvian highlands.Taenia solium infection in a rural community in the Peruvian Andes.Can Taenia solium latent post-oncospheral stages be found in muscle tissue of cysticercosis-infected pigs (Sus scrofa)?Comparison of the peptidase activity in the oncosphere excretory/secretory products of Taenia solium and Taenia saginata.Blood-brain barrier disruption and angiogenesis in a rat model for neurocysticercosisIN VITRO ONCOSPHERE-KILLING ASSAYS TO DETERMINE IMMUNITY TO THE LARVAE OF TAENIA PISIFORMIS, TAENIA OVIS, TAENIA SAGINATA, AND TAENIA SOLIUMTrypanocidal properties, structure–activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivativesEvaluation of the enzyme-linked immunoelectrotransfer blot (EITB) for ovine hydatidosis relative to age and cyst characteristics in naturally infected sheepExperimental infection model for Taenia solium cysticercosis in swinePersistence of passively transferred antibodies in porcine Taenia solium cysticercosiss
P50
Q24599487-8230452B-1FB1-471B-8FB6-AC63180CDF22Q28472998-EF93A39C-9B80-4328-9BDF-718431884563Q30364569-D2AAE486-5AAB-4804-97AB-386ACB36ECC2Q33587293-508EA985-5C91-4ED9-9295-A4B3674721C2Q33719577-C04EA299-793D-4E41-9D7D-5950AF7CB6DDQ33754264-36A40C1B-2291-4557-B2A3-B959466C2D0DQ33834064-1B2B9638-D1AF-4892-A932-C60268A8461DQ34131239-3F816FF1-2220-45B0-88D4-CA136DEC22A6Q34593040-66D271E5-6C34-4776-B8BA-D07211B508E7Q34624995-5FD9809D-0FA5-45A9-81D3-AD34DD211B8FQ35054854-6E3BB164-8707-4C2B-A3A4-43E53D7B576EQ35069952-668F98FC-0086-4162-9154-DB8CEEE22B31Q35117410-317F938E-C2ED-48FA-AF04-AFD02AD221DEQ35217173-0D3C0CF0-3EE3-4B57-9D09-AEA9F58ED799Q35637312-63855E64-FF8A-47A4-A324-BD5268DFEC17Q35692032-D9CBC01C-2558-40B8-AFC9-6164F0E79CE8Q35739946-8E854938-661F-4E08-B3E9-92B76E47132FQ35999719-5D80BBFA-BA2E-42DF-AB9A-E878ED2A364DQ36567682-98FFB70A-679B-4CB8-8CBE-1503801A248EQ36869503-1570D8C3-12F5-43B4-A1A1-6892443069A5Q36933174-406358B2-F9F2-442B-9FA9-8D159B2365F5Q39540206-6D50605B-004E-4F1C-B0B1-977436A5C141Q39938801-FB8509EC-939F-4444-A5B6-A778A54BB87DQ41087456-BCA7D589-AFC9-4EDB-9FF7-E7AE09277871Q42112364-2327080B-B041-4534-B298-4BA63381B94DQ42355911-9F8F760E-B292-4D8B-A8F9-DF4A6BCAC9D9Q43214454-CA135D6B-1AE5-4830-A04C-7D2BDBB35B06Q43230066-B30244FF-DFF2-46F4-A0A8-9C1B0215F091Q44332126-63159826-0589-4CCC-B5D0-A4A290BECDE6Q44494641-ACE8494D-D562-478D-B3E3-C3EDBF9077E0Q46509757-68667881-0A64-4B7F-8FD0-E9FE0F195444Q46964912-97ADEFD9-50F3-46CB-9C8C-10C0BD954BC2Q57468975-57072AD2-9870-4072-AFDD-EE70218380C6Q57804912-0D426DED-9364-464D-BF69-9F4229C90BE0Q58869303-76454D66-7A24-41FA-B415-2A50915BF38EQ58869320-BA92DE64-9385-4A3F-AC44-14FEDF6C3D2AQ58869326-ACF0468D-EEDA-4CC3-BB0E-79D322A7F1E7Q58869331-5DCDC19A-E657-46F0-8AC7-BB5168FE3FBC
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
researcher
@en-gb
հետազոտող
@hy
name
Manuela Verastegui
@ast
Manuela Verastegui
@en
Manuela Verastegui
@en-gb
Manuela Verastegui
@es
Manuela Verastegui
@nl
Manuela Verastegui
@sl
type
label
Manuela Verastegui
@ast
Manuela Verastegui
@en
Manuela Verastegui
@en-gb
Manuela Verastegui
@es
Manuela Verastegui
@nl
Manuela Verastegui
@sl
prefLabel
Manuela Verastegui
@ast
Manuela Verastegui
@en
Manuela Verastegui
@en-gb
Manuela Verastegui
@es
Manuela Verastegui
@nl
Manuela Verastegui
@sl
P106
P1153
7004202872
P21
P31
P496
0000-0002-7500-1353